43 results
8-K/A
EX-99.5
MIRM
Mirum Pharmaceuticals, Inc.
2 Nov 23
Financial Statements and Exhibits
4:05pm
are not anticipated to last beyond 12 months post-close.
To adjust for a retention bonus provided to certain Bile Acid Business employees. The retention … bonus is earned over 18 months of continuous employment with the Company, reflected as $0.3 million for the year ended December 31, 2022, and $0.2
8-K
EX-10.1
MIRM
Mirum Pharmaceuticals, Inc.
11 Sep 23
Departure of Directors or Certain Officers
4:16pm
payroll deductions and withholdings, paid on the Company’s normal payroll schedule.
Annual Bonus: You will also be eligible to earn an annual … performance bonus, with a target bonus of 40% of your annual base salary, based on the attainment of individual and/or Company objectives, and pro-rated
8-K
MIRM
Mirum Pharmaceuticals, Inc.
11 Sep 23
Departure of Directors or Certain Officers
4:16pm
for the following compensation: (i) an annual base salary of $485,000 per year, (ii) eligibility to receive an annual performance bonus with a target amount … of his then-current annual base salary payable for 18 months, (ii) payment of 150% of his then-current target annual performance bonus, (iii
8-K
y3nno8enzkz gnx
30 Aug 23
Departure of Directors or Certain Officers
4:15pm
8-K
EX-10.1
l3v3554
30 Aug 23
Departure of Directors or Certain Officers
4:15pm
8-K
EX-2.1
x872b0oftsue qt4n1w
17 Jul 23
Mirum Pharmaceuticals Enters Agreement to Acquire Bile Acid Product Portfolio for the Treatment of Rare Liver Diseases from Travere Therapeutics
8:16am
8-K
EX-1.1
5rykgy8j8zi 2ofg98
10 Aug 22
Other Events
12:00am
8-K
EX-1.1
vhiwsk1wl gkfujckye0
15 Dec 20
Other Events
5:09pm
DEF 14A
nn8ro4tc
29 Apr 20
Definitive proxy
4:15pm
8-K
za1xzxj7jom8um8
14 Jan 20
Departure of Directors or Certain Officers
4:00pm
424B4
lybr71
9 Jan 20
Prospectus supplement with pricing info
5:11pm
8-K
EX-10.1
oc3vm2h1gaa
27 Dec 19
Departure of Directors or Certain Officers
4:15pm